The E4orf4 protein of human adenovirus induces p53-independent apoptosis, a process that may promote cell death and viral spread. When expressed alone, E4orf4 kills transformed cells but not normal human cells. The only clear target of E4orf4 in mammalian cells is the Ba (B55) subunit of protein phosphatase 2A (PP2A), a member of one of three classes of regulatory B subunits. Here we report the eects of E4orf4 in Saccharomyces cerevisiae, which encodes two PP2A regulatory B subunits, CDC55 and RTS1, that share homology with mammalian B and B' subunits, respectively. E4orf4 expression was found to be toxic in yeast, resulting in the accumulation of cells in G2/M phase that failed to grow upon removal of E4orf4. E4orf4-expressing yeast also displayed an elongated cell morphology similar to cdc55 deletion strains. E4orf4 required CDC55 to elicit its eect, whereas RTS1 was dispensable. The recruitment of the PP2A holoenzyme by E4orf4 was entirely dependent on Cdc55. These studies indicate that E4orf4-induced apoptosis in mammalian cells and cell death in yeast require functional interactions with B-type subunits of PP2A. However, some inhibition of growth by E4orf4 was observed in the cdc55 strain and with an E4orf4 mutant that fails to interact with Cdc55, indicating that E4orf4 may possess a second Cdc55-independent function aecting cell growth. Oncogene (2001) 20, 5279 ± 5290.
Introduction
Studies on the interactions between human adenovirus products and host cell proteins have proven extremely useful in gaining insights into a number of cellular processes (Moran, 1993; Mumby, 1995) . Infection by adenoviruses or expression of certain individual viral products induces apoptosis, although this process is at least partially blocked by additional viral proteins (Roulston et al., 1999) . Some time ago adenoviruses were shown to induce both p53-dependent and p53-independent apoptosis (Teodoro et al., 1995) . Induction of p53-independent apoptosis was mapped to the E4orf4 product of open reading frame 4 encoded by the adenovirus early region 4 transcription unit Marcellus et al., 1996 Marcellus et al., , 1998 Shtrichman and Kleinberger, 1998) . Although E4orf4 is expressed early after adenovirus infection, we believe that it also functions later to contribute to cell death and subsequent release of viral particles (Roulston et al., 1999) . Another viral protein, the E3-11.6 kDa product (also called the`adenovirus death protein') is also clearly involved in this process (Tollefson et al., 1996) . Expression of E4orf4 in Chinese hamster ovary cells in the absence of other viral products and under an inducible promoter causes most of the phenotypic changes associated with apoptosis, including internucleosomal DNA degradation, externalization of phosphatidylserine, membrane blebbing, cytoplasmic vacuolization and hyperpolarization of the mitochondrial membrane Marcellus et al., 1998; Shtrichman and Kleinberger, 1998) . Although E4orf4 has been found to elicit little eect on normal human cells, it appears to kill a wide range of human cancer cells (Shtrichman and Kleinberger, 1998; Shtrichman et al., 1999; Marcellus and Branton, in preparation) . Thus it may be of value as an anticancer agent involving gene therapy or selectively-replicating viruses.
Previous studies have correlated E4orf4 expression with the hypophosphorylation of several proteins, including the adenovirus E1A protein, cellular transcription factors involved in viral gene expression, and splicing factors (Kanopka et al., 1998; Muller et al., 1992; Whalen et al., 1997) . Although E4orf4 has no intrinsic phosphatase activity, it was shown to associate with protein phosphatase 2A (PP2A) through interactions with the Ba regulatory subunit (Kleinberger and Oncogene (2001) 20, 5279 ± 5290 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc Shenk, 1993) . PP2A is an abundant serine-threonine phosphatase with pleiotropic activities aecting metabolism, RNA splicing, translation, morphogenesis, development, and cell cycle progression (Goldberg, 1999; Lechward et al., 1999; Mumby and Walter, 1993; Stark, 1996) . The holoenzyme exists in multiple forms as a heterotrimer composed of a catalytic C subunit and A and B regulatory subunits. In mammalian cells the A and C subunits, which comprise the core enzyme, are ubiquitous, each existing in two isoforms. The 65 kDa A subunit is composed of 15 imperfect repeats of 39 amino acids, termed HEAT (huntingtin-elongation-Asubunit-TOR) motifs that are believed to mediate protein ± protein interactions (Groves et al., 1999; Hemmings et al., 1990; Walter et al., 1989) . The 37 kDa catalytic subunit is able to bind to repeats 11 ± 15 while the B subunit binds to repeats 1 ± 10 of the A subunit (Ruediger et al., 1992 (Ruediger et al., , 1994 . To date, about twenty B subunits have been cloned and these have been grouped into three classes, designated as B (or B55), B' (or B56) and B''. The B class proteins all have molecular masses of about 55 kilodaltons (kDA) and include at least four members, Ba, Bb, Bd and Bg (Mayer et al., 1991; Pallas et al., 1992; Strack et al., 1999; Zolnierowicz et al., 1994) . Five genes (a, b, g, d, e) producing at least 13 splice variants make up the B' (B56) class (Csortos et al., 1996; McCright et al., 1996a,b; McCright and Virshup, 1995) . The B'' class contains at least three genes PR72/130, PR48 and PR59 (Hendrix et al., 1993; Voorhoeve et al., 1999; Yan et al., 2000) . Recently, two additional B-type subunits have been identi®ed and represent a putative B''' (B93/110) family (Moreno et al., 2000) . The major forms of PP2A are AC dimer and ABC trimer which exist in equal abundance in cells, each form having dierent substrate speci®city (Cegielska et al., 1994; Kremmer et al., 1997) . Depending on the speci®c B subunit present in the heterotrimeric holoenzyme, phosphatase activity against speci®c substrates is either promoted or inhibited (Cegielska et al., 1994; Ferrigno et al., 1993; Kamibayashi et al., 1994) . It is therefore tempting to propose that, through its interaction with Ba, E4orf4 may modulate the substrate speci®city and/ or subcellular localization of the Ba-containing PP2A enzymes. Recently it has been reported that E4orf4 also associates with the mammalian tyrosine kinase Src (Lavoie et al., 2000) . The importance of this interaction remains to be established.
In a recent study, our group used a panel of E4orf4 point mutants to correlate E4orf4 and Ba binding to cell killing (Marcellus et al., 2000) . These mutants were classi®ed into three groups. Class I E4orf4 mutants do not interact with PP2A, show no associated phosphatase activity and do not promote apoptosis. Similar mutants have also been identi®ed by another group (Shtrichman et al., 1999) . Class II mutants bind Ba and associate with signi®cant levels of phosphatase activity, but are defective for killing. These results seem to indicate that the E4orf4 ± PP2A complex is required, but not sucient to promote cell death. Alternatively, class II mutants may interact with Ba but fail to elicit the appropriate biological eect on PP2A due to inexact binding. It is even possible that these mutant E4orf4 proteins may interact with Ba in vitro, but not in vivo. Another set of E4orf4 mutants (Class III) were essentially wild-type.
PP2A of Saccharomyces cerevisiae is very similar to the mammalian enzyme with respect to organization, substrate speci®city and sensitivity to inhibitors (Cohen et al., 1989) . In yeast, the catalytic C subunit is encoded by PPH21 and PPH22 (Sneddon et al., 1990) . The products of PPH21 and PPH22 genes share 89% amino acid sequence identity and both are at least 75% identical to the human C subunit peptide sequences (Costanzo et al., 2000) . Pph21 and Pph22 are unique in that unlike C subunits of other species, they have acidic amino terminal extensions of 60 and 68 residues, respectively, and these stretches are 48% identical (Ronne et al., 1991) . In S. cerevisiae the catalytic subunits are dispensable for cell growth when deleted individually, but strains lacking both C subunits, as well as a related gene, PPH3, are non-viable (Ronne et al., 1991) . TPD3 encodes the only A subunit and like the mammalian protein, it contains 15 non-identical repeats of 39 residues (van Zyl et al., 1992) . Only two B-type regulatory subunits exist in yeast and are encoded by CDC55 and RTS1, representing the B and B' families, respectively (Healy et al., 1991; Shu et al., 1997) . cdc55 strains are cold sensitive and produce cells that are abnormally elongated due to defects in cytokinesis and/or septation, implicating PP2A in cell morphogenesis (Healy et al., 1991) . rts1 strains show reduced growth at 308C, and at 378C cells accumulate with a 2 n DNA content (Shu et al., 1997) .
The high degree of conservation of the PP2A enzyme from mammals to yeast suggests that S. cerevisiae could provide a genetically tractable system in which to study the molecular mechanism of the E4orf4 ± PP2A complex. Although yeasts do not undergo apoptosis, they do possess many comparable cell cycle signalling pathways, and in fact expression of the mammalian pro-apoptotic Bax protein was found to induce cell death (Greenhalf et al., 1996; Zha et al., 1996) . In addition, studies in yeast would allow a direct genetic analysis of the requirement of E4orf4 for the B regulatory subunit, as the work thus far in mammalian systems has been largely correlative. In particular, they may also allow determination of the kind of biochemical eect E4orf4 exerts on PP2A, including whether E4orf4 alters PP2A substrate speci®city or inhibits or activates PP2A activity more generally. Such information, which may be more readily obtained in yeast studies, could provide critical insights into the mechanism of the E4orf4 ± PP2A pro-apoptotic pathway in mammalian cells. For yeast to represent a feasible system in which to conduct such studies, it was hoped that E4orf4 would elicit a signi®cant biological eect. In addition, it would be of great interest to determine if E4orf4-B subunit interactions are conserved. The results of the present study indicate that the molecular interactions between E4orf4 and PP2A are indeed conserved in S. cerevisiae. While the apoptotic eect of E4orf4 in transformed mammalian cells has been correlated with its interaction with the Ba subunit, here we have used the yeast system to demonstrate that the toxicity conferred by E4orf4 expression is also largely dependent on CDC55, and not RTS1. Nevertheless, some growth inhibition was also detected in the absence of E4orf4 ± Cdc55 interactions, suggesting that E4orf4 may possess a second mechanism of limiting cell growth.
Results
Conditional expression of E4orf4 in yeast renders cells inviable and promotes an abnormal elongated morphology similar to cdc55 strains HA-tagged E4orf4 cDNA was subcloned into the episomal yeast vector pYES2 under the control of the GAL1 promoter. The GAL1 promoter is repressed in the presence of glucose and induced by galactose, thus allowing dierential expression of E4orf4 based on the carbon source in the growth medium. To determine if E4orf4 expression had any eect on yeast colony growth, spotting assays were performed and the eects of E4orf4, the E311.6K`adenovirus death protein', Bax, or empty pYES2 vector, on cell growth were compared. Although the toxic eects of E311.6K are unknown, Bax is a cellular pro-apoptotic protein that has previously been shown to be lethal in yeast (Greenhalf et al., 1996; Zha et al., 1996) . Figure 1b shows that all proteins were expressed at high levels. Two closely-migrating forms of E4orf4 were apparent, as seen in mammalian cells Marcellus et al., 2000) . The molecular basis for the presence of two E4orf4 species is not known. Figure 1a shows that E4orf4 expression signi®cantly delayed colony growth compared to the vector control. The E311.6K protein had some minor eect, which became undetectable past day 3, and was not considered further. As demonstrated previously, Bax expression resulted in a dramatic cessation of colony growth. E4orf4 expressed in the SEY6210 diploid strain also resulted in impaired growth (data not shown). Furthermore, expression of E4orf4 in EGY48 and BY4742 haploid yeast strains also gave comparable growth phenotypes (data not shown). To assess whether or not E4orf4 expression is lethal to yeast, a colony formation assay was performed. Cells were cultured in glucose-based medium, transferred to glycerol containing medium for 2 h and then ®nally to galactose medium. At various times following the induction of E4orf4, Bax or the vector control, approximately 300 cells were plated onto glucose-based medium. The number of cells which remained viable and thus formed colonies on the plates were counted. Figure 1c shows that cells expressing E4orf4 formed signi®cantly fewer colonies than the vector control and displayed a toxicity similar to the positive control for cell death, Bax. Cells were collected from the liquid cultures at the indicated times post-galactose induction Figure 2b shows that expression of E4orf4 induced an abnormal elongated morphology in about 25 ± 35% of cells in the culture that was not apparent with vector alone (Figure 2a ). This aberrant morphology was highly similar to that observed in cdc55 strains at low temperatures, where over 90% of the cells were elongated (Figure 2c ). Cdc55 shares 47% identity and 61% similarity with the human Ba subunit of PP2A (Costanzo et al., 2000) . This common morphological phenotype suggested that E4orf4 may be targeting Cdc55, the yeast homologue of the mammalian Ba subunit, possibly indicating a molecular link between E4orf4 function in mammalian cells and yeast.
E4orf4 requires CDC55 to elicit full toxicity in yeast
Previous work using E4orf4 point mutants has correlated induction of apoptosis in mammalian tumour cell lines with binding of E4orf4 to the Ba subunit of PP2A (Marcellus et al., 2000; Shtrichman et al., 1999) ; however, more direct genetic analyses in mammalian cells have not been possible due to the lack of appropriate`knock-out' cell lines. To demonstrate such a direct requirement for the B subunit, a cdc55 strain was created using standard protocols that allow replacement of the CDC55 gene with a kanamycin cassette. Spotting assays were then performed using either wild type yeast or the cdc55 strain transformed with either empty vector or one expressing E4orf4. Figure 3b shows the expression of E4orf4 in these cells following Western blotting of equal amounts of cell protein. Figure 3a shows that in the absence of CDC55, the E4orf4-induced growth delay was greatly diminished. These results indicate that E4orf4 mediates much of its eect in yeast via the Cdc55 subunit; however, as illustrated in Figure  3a , and as seen repeatedly, a slight degree of growth inhibition was nevertheless apparent in the cdc55 cells. These results suggested that E4orf4 may aect growth via two mechanisms, one dependent upon and one independent of Cdc55 (see more below). In addition, the level of expression of E4orf4 in the cdc55 strain was repeatedly observed to be greater than in wild type cells. While the basis for this dierence is unclear, it is possible that the cells attempt to down regulate E4orf4 expression when the Cdc55 target is present in eort to reduce E4orf4-induced, Cdc55-dependent eects on growth. Figure  3c demonstrates that complementation of the cdc55 strain with CDC55 on a low copy plasmid (p414ADH ± FlagCDC55) can restore the growth inhibition of E4orf4.
E4orf4 requires Cdc55 to delay yeast cells in mitosis
To determine if cells accumulate in a speci®c phase of the cell cycle, E4orf4-and vector-expressing yeast were analysed by FACS at 24 h post-induction. Figure 4a shows that wild type cells expressing E4orf4 contained a greatly increased population of 2 n cells, suggesting that E4orf4 induces a growth arrest or growth slowdown during the G2/M transition. E4orf4 expression in the cdc55 strain, however, did not appear to have any pronounced eects on the cell cycle pro®le. The Cdc28-CyclinB complex of cells that are arrested in mitosis are able to maintain kinase activity since mitotic cyclins are not degraded. If cells expressing E4orf4 were arrested or accumulating in mitosis, the Cdc28 ± CyclinB complex should remain active. To further investigate this possibility immunoprecipitation-kinase assays were performed. Wild type or cdc55 yeast expressing vector or E4orf4 were lysed 24 h post-galactose induction and the Cdc28 ± Cyclin B complex was immunoprecipitated using anti-Clb2 antibody. The immunoprecipitates were then tested Figure 2 E4orf4 expression in wild type yeast confers an elongated cell morphology. Yeast transformed with vector alone (a) or E4orf4 (b) were cultured in galactose-based medium at 308C. (c) The cdc55 strain was grown in galactose medium at 188C. Live cells were mounted onto glass slides and viewed at 1006magni®cation with a light microcope (Axioplan, Ziess) using Nomarski DIC optics. Images were captured and visualized on a PC computer using a digital-output CCD camera and SPOT Software v2.2 (Diagnostic Instruments) for their ability to phosphorylate H1 histone. As is evident in Figure 4b , Clb2-immunoprecipitates from wild type yeast expressing E4orf4 phosphorylated histone H1 and displayed a much higher Cdc28 ± Cyclin B kinase activity compared to the vector control. As a positive control, wild type cells containing vector alone were treated with nocodazole to induce mitotic arrest, and immunoprecipitates from these cells also displayed high levels of phosphorylated histone (Figure 4b ). In contrast, immunoprecipitates from the cdc55 strain expressing E4orf4 did not show any eect on the cell cycle as H1 phosphorylation by the Cdk complex was similar to that in the vector control.
E4orf4 requires interaction with Cdc55 to recruit the PP2A holoenzyme
To determine if the requirement for CDC55 in the E4orf4-induced slow growth phenotype involves an interaction between E4orf4 and Cdc55, co-immunoprecipitation experiments were carried out. Cells containing a CDC55 disruption were co-transformed with HAtagged E4orf4 and/or Flag-tagged Cdc55. Whole cell extracts prepared at 24 h post-galactose induction were immunoprecipitated with either anti-HA or anti-Flag antibodies, and following separation by SDS ± PAGE and transfer, Western blotting was performed using the appropriate antibodies. Figure 5b (lane 4) and 5d (lane 4) show that E4orf4 and Cdc55 co-immunoprecipitated, indicating that these proteins associate in the same complex in yeast. Previous studies in mammalian cells demonstrated that all three subunits of PP2A can be found in E4orf4 complexes (Kleinberger and Shenk, 1993) . Western blotting analysis of anti-Flag immunoprecipitates using a rabbit polyclonal serum against the Tpd3 A subunit of PP2A indicated that Tpd3 coimmunoprecipitated with Flag-Cdc55 in the absence or presence of E4orf4 (Figure 5f , lanes 3 and 4, respectively); however, Tpd3 only co-immunoprecipitated with HA-E4orf4 in cdc55 cells that expressed exogenous Flag-Cdc55 (Figure 5c, lanes 2 and 4) . These results indicated that recruitment of Tpd3 by E4orf4 absolutely requires Cdc55.
To characterize the E4orf4 ± PP2A complex in yeast further, wild type cells containing vector alone or the HA-E4orf4 galactose-inducible plasmid were transformed with DNA vectors expressing either Flagtagged PPH21 or PPH22, which encode the PP2A catalytic C subunits of S. cerevisiae. These cells were cultured in the presence of galactose for 24 h to allow co-expression of E4orf4 and the Flag-tagged C subunits. Immunoprecipitation with HA antibody followed by Western blotting with anti-Flag revealed that both Pph21 and Pph22 can be co-immunoprecipitated with E4orf4 (Figure 6b , lanes 5 and 6, respectively). In the reciprocal experiment, immunoprecipitation with Flag-antibody and blotting against the HA epitope con®rmed that E4orf4 formed complexes with both Pph21 and Pph22 in the presence of endogenous Cdc55 (Figure 6d , lanes 5 and 6, respectively). Figure 6c (lanes 4 ± 6) again shows that endogenous Tpd3 associates with E4orf4 complexes. The association of Tpd3 with both Pph21 and Pph22 was also apparent both in the presence (Figure 6f , lanes 5 and 6) and absence ( Figure 6f, lanes 2 and 3) of E4orf4. Thus the results shown in Figures 5 and 6 indicated that E4orf4 associates with the entire yeast PP2A holoenzyme as long as Cdc55 is present.
Correlation of Cdc55 binding, phosphatase activity and elongated cell morphology to E4orf4-induced killing using E4orf4 point mutants
To correlate E4orf4-induced toxicity with binding to Cdc55 and associated phosphatase activity, use was Wild type and cdc55 cells were transformed with pYES2 vector or pYES2 ± HAE4orf4. Yeast were serially diluted and spotted onto glucose-or galactose-based selective plates followed by incubation at 308C. Photographs were taken at day 2 post-induction. (b) Whole cell extracts prepared from yeast cells collected from the plates in panel (a) were subject to SDS ± PAGE immunoblot assay using anti-HA antibody. Lanes 1 and 3 represent vector alone and lanes 2 and 4 represent E4orf4 expression. (c) cdc55 yeast were transformed with the indicated combinations of plasmid DNA (i.e. v=pYES2 or p414ADH, pYES2 ± HAE4orf4, p414ADH ± FlagCDC55). Serially diluted yeast were spotted onto glucose-or galactose-based selective medium followed by incubation at 308C. Photographs were taken at day 2 post-induction made of certain E4orf4 point mutants. These mutants had previously been analysed for the ability of their altered E4orf4 products to bind to the mammalian Ba subunit, to associate with PP2A activity, and to induce cell death in mammalian tumour cell lines (Marcellus et al., 2000) . R81/F84 is a Class I mutant containing alanine residues in place of R81 and F84. R81F84 does not bind Ba, lacks associated phosphates activity, and does not kill human tumour cells. K88 contains an alanine residue in place of K88 and is a representative of Class II mutants, which bind Ba at reasonable levels, have associated phosphatase activity, but which are defective for killing. S106 contains alanine in place of S106 and is a class III mutant with a pro®le identical to wild type E4orf4 and they are comparable with respect to binding Ba, associated phosphatase activity and cell killing. To determine the ability of these E4orf4 point mutants to interact with Cdc55 and to associate with phosphatase activity, co-immunoprecipitation experiments were performed in the cdc55 strain transformed with vector DNAs expressing Flag-CDC55 and wild type HA-E4orf4 or the HA-E4orf4 point mutants. Immunoblotting with anti-HA antibodies con®rmed that high levels of all mutants were expressed ( Figure 7c, bottom panel) . Immunoprecipitation with anti-Flag antibodies and Western blotting with anti-HA antibodies (Figure 7c , top panel) indicated that both the S106 and K88 mutant E4orf4 proteins co-precipitated with Flag-CDC55 (lanes 8 and 9) about as well as did wild type E4orf4 (lane 7). Figure 4 E4orf4 induces a mitotic delay/arrest and maintains Cdc28 kinase activity only in the presence of CDC55. (a) Wild type or cdc55 cells expressing vector or E4orf4 were collected 24 h post galactose induction, prepared for staining with propidium iodide, and subject to FACS analysis. M1 represents 1 n DNA content (G1 cells), M2 denotes cells in S phase, and M3 represents 2 n DNA content (G2/M cells). (b) Whole cell extracts from wild type or cdc55 cells expressing vector or E4orf4 were immunoprecipitated with Clb2 antibody. Whole cell extracts from wild type cells treated with 10 mg/ml of nocodazole for 3 h were also subjected to immunoprecipitation with anti-Clb2 and served as a positive control for mitotic arrest. Kinase assays were performed to determine the activity of the Cdc28 ± Clb2 complex towards histone H1 in vitro. The lanes shown represent samples processed at the same time, run on the same gel and exposed to ®lm for an identical period of time Binding of the R81/F84 E4orf4 protein (lane 10) was undetectable. Thus the class I mutant R81/F84 was totally defective for binding of both yeast Cdc55 and the mammalian Ba subunit. Extracts were also immunoprecipitated with anti-HA antibodies and associated phosphatase activity was assayed by measuring phosphate release from a synthetic peptide containing a universal phosphoserine phosphatase substrate site (Figure 7d ). Only basal levels of phosphatase activity were detected in HAE4orf4-immunoprecipitates lacking the Cdc55 subunit. Wild type E4orf4 and S106 in cells reconstituted with Cdc55 displayed high levels of phosphatase activity. K88 was somewhat defective for phosphatase activity and R81F84 displayed low levels comparable to the vector controls. The phosphatase activity associated with Flag-CDC55 was also determined in cdc55 cells in the absence and presence of E4orf4. As can be seen in Figure 7d (lower histogram) there was no dierence in relative phosphatase activity suggesting E4orf4 has no intrinsic aect on PP2A.
These E4orf4 mutants were also tested in wild type haploid yeast for colony growth and cell morphology. Figure 7b shows an anti-HA blot of whole cell extract con®rming that the mutant E4orf4 proteins were expressed at high levels. Figure 7a shows that following galactose induction, S106 induced toxicity as eciently as did wild type. Both K88 (class II) and R81F84 (class I) yielded a reduced, although still detectable, eect on cell growth. In the case of K88, this eect could have resulted from interactions with Cdc55; however, such was unlikely to be the case with R81/F84 as it did not appear to interact with Cdc55. These results again suggested that E4orf4 possesses a second growth inhibitory function that is independent of interactions with Cdc55. To examine the eects of mutant E4orf4 proteins further, cells were collected from these plates and their morphologies were examined. As shown previously in Figure 2b , cells expressing wild type or S106 E4orf4 contained a high percentage (25 ± 30%) of elongated aberrent cells (data not shown). Those expressing the R81/F84 mutant were entirely of normal morphology and resembled those containing vector alone, as shown in Figure 2a (data not shown). Cells expressing the K88 mutant also displayed largely normal morphology, although a few cells (41%) did have an elongated morphology (data not shown). These data suggested that induction of the elongated morphology requires ecient and functional binding of E4orf4 to Cdc55.
E4orf4 does not require Rts1 to induce toxicity in yeast
Budding yeast contain only one B/B55-like PP2A subunit (Cdc55) and one B'/B56-like species, Rts1 (Shu et al., 1997) . The data presented in Figure 5 implied that E4orf4 does not interact with Rts1, as Tdp3 was found to co-immunoprecipitate with E4orf4 only in the presence of Cdc55. This observation suggested that Cdc55 and not Rts1 was required for the E4orf4-induced growth eect. To determine if Rts1 was required for E4orf4 function, wild type E4orf4 and E4orf4 point mutants were expressed in wild type yeast or in an rts1 strain. Haploid wild type yeast or yeast containing an RTS1 deletion were transformed with the indicated plasmid DNAs and spotting assays were performed. Figure 8b shows that all E4orf4 proteins were expressed at high levels. Figure 8a shows that wild type and S106 E4orf4 induced toxicity as well or better in the rts1 strain compared to wild type cells, indicating that Rts1 is not required for E4orf4 function. Again the K88 and R81/F84 mutants induced a, modest eect in both wild type and rts1 cells. Thus, although the Cdc55 PP2A B subunit is required for E4orf4-induced slow growth, Rts1 is not. Figure 5 E4orf4 requires Cdc55 to recruit the PP2A complex. The cdc55 strain was co-transformed with DNA from the indicated plasmids (pYES2, p424GAL1, pYes2 ± HAE4orf4 or p424GAL ± FlagCDC55) and whole cell extracts were prepared 24 h post-galactose induction. Extracts were incubated with anti-HA or anti-Flag antibodies. Immunoprecipitates were separated by SDS ± PAGE and subjected to immunoblotting with anti-HA (a,d), anti-Flag (b,e) or rabbit polyclonal anti-Tpd3 antibodies (c,f)
Discussion
Previous studies correlated the binding of E4orf4 to the Ba subunit of PP2A with the induction of p53-independent apoptosis in mammalian cell killing (Marcellus et al., 2000; Shtrichman et al., 1999) . Little is known about the eects of E4orf4 on PP2A activity or what the potential critical PP2A substrates might be that eect the cell death response. Yeasts provide more genetically amenable systems than mammalian cells to allow such questions to be addressed. In this study we have demonstrated the feasibility of using yeast as a model system for further investigation of the eects of E4orf4 on PP2A functions. E4orf4 expression is toxic to yeast and confers a readily identi®able elongated morphology. Using standard genetic manipulations the B-like subunit CDC55 was found to be highly important for the E4orf4-induced phenotype, whereas RTS1, which encodes the B'-like PP2A regulatory subunit, is not. As in mammalian cells, E4orf4 binds to the Cdc55 B subunit and through this interaction recruits the entire PP2A complex. Such complexes, also containing Tpd3 and Pph21 or Pph22, possessed high levels of phosphatase activity as determined by in vitro assays. In the absence of Cdc55, neither Tpd3 ( Figure  5c ) nor the Pph21 or Pph22 catalytic subunits (data not shown) could be found associated with E4orf4. Similarly, in cdc55 cells E4orf4 did not show associated phosphatase activity in the absence of Cdc55. Although one report has suggested that E4orf4 binds both to Ba and several members of the B' class (Shtrichman et al., 2000) , our group has found that binding occurs only with B class family members (Marcellus and Branton, in preparation) . Nevertheless, there is general consensus that the known biological eects of E4orf4 are elicited exclusively via interactions with B class subunits of PP2A.
Expression of both Class I or Class II E4orf4 mutants induced a modest eect on cell growth even though binding to Cdc55 was undetectable with the former. Identi®cation of Class II E4orf4 mutants, which bind the Ba subunit but fail to kill tumour cells eectively, suggested that binding to B is required but not sucient to elicit apoptosis. The present studies using the K88 Class II mutant in yeast also suggests that E4orf4 requires binding to Cdc55 to elicit its eect, but this binding is not sucient to have a full eect in yeast. Cdc55 is clearly important, as much of the E4orf4's toxicity is relieved in cdc55 strains; however, the presence of some residual inhibitory eect with E4orf4 in these cells (Figure 4a) , and with the Class I and Class II mutants in wild type cells (Figures 7a and 8a ) clearly suggest that a Cdc55-independent function may also exist. While the R81/ F84 mutant does not bind Cdc55 it does produce some slow growth eect. Analogous to the results obtained in mammalian cells with the Class II mutants, the K88 mutant interacts with Cdc55; however, K88 yields a partial toxicity as seen with R81F84, indicating either that the E4orf4 ± PP2A complex is required but not sucient for E4orf4 to elicit a full eect in yeast, or that the complex formed with the K88 mutant is not biologically functional.
Of some interest was the fact that while these mutants induced a partial growth delay, they were not sucient to generate the aberrant elongated morphology associated with a signi®cant proportion of E4orf4-expressing yeast cells. In the case of R81F84 this eect can be explained by the absence of E4orf4 and Cdc55 interactions, suggesting that a stable Figure 6 E4orf4 co-immunoprecipitates with PP2A complexes containing both forms of the yeast catalytic subunit. Wild type yeast were co-transformed with plasmids expressing the indicated proteins and cells were collected 24 h post-galactose induction. Whole cell extracts (wce) were prepared and subjected to immunoprecipitation with antibody against the Flag or HA epitope. Proteins were separated by SDS ± PAGE followed by Western blotting with anti-HA (a,d), anti-Flag (b,e), or anti-Tpd3 antibodies (c,f). Protein expression from wce was also determined (g,h,i) E4orf4 ± PP2A complex is required for this phenotype. However, the K88 mutant, which does interact with Cdc55, did not show any signi®cant morphological abnormalities, indicating either that the interaction between E4orf4 and Cdc55 is insucient to promote this phenotype or that the complex of PP2A with this mutant E4orf4 is non-functional in this respect. This observation is in accord with results of studies that have demonstrated that PP2A is involved in yeast cell morphogenesis (Evans and Stark, 1997; Healy et al., 1991; Lin and Arndt, 1995; Ronne et al., 1991; van Zyl et al., 1992) . It has previously been reported that strains harbouring cdc55rts1 double deletions show extremely slow growth compared to wild type cells or those lacking just one of the genes encoding these PP2A subunits (Shu et al., 1997) . We demonstrated that E4orf4 does not require RTS1 as E4orf4 expression in the rts1 strain induced a slow growth phenotype similar to that which would be expected in a cdc55/rts1 strain, raising the possibility that E4orf4 could inactivate the Cdc55 subunit. This possibility seems unlikely, however, as the E4orf4-induced D Figure 7 Analysis of colony growth, Cdc55 binding and phosphatase activity using E4orf4 point mutants. (a) Yeast transformed with plasmids expressing the indicated HA-tagged proteins were spotted onto glucose-or galactose-based medium and incubated at 308C. Pictures were taken after 3 days. (b) Anti-HA Western blot of whole cell extracts prepared from cells expressing the indicated proteins. (c) Co-immunoprecipitation experiments using whole cell extracts prepared from the cdc55 strain transformed with the indicated plasmids (CDC55 is Flag-tagged and E4orf4 is HA-tagged). (d) Upper panel: Analysis of phosphatase activity associated with E4orf4 and E4orf4 mutants. cdc55 cell extracts containing the indicated plasmids (CDC55 is Flag-tagged and E4orf4 is HAtagged) were subject to immunoprecipitation with HA antibody. The results for the average of three independent experiments are relative to results obtained with wild type E4orf4 and Cdc55, which was set at 100 (arbitrary standardized units). Lower panel: Phosphatase activity associated with FlagCDC55 in the presence and absence of E4orf4. cdc55 cell extracts were immunoprecipitated with Flag antibody. The result is averaged from three independent experiments and is relative to results obtained with Cdc55 alone, which was set at 100 (arbitrary standardized units). Immunoprecipitates were assayed for PP2A activity as described in Materials and methods phenotype does not mimic the cdc55 strain. While cdc55 strains grow somewhat slower than wild type strains at 308C, the eect of E4orf4 expression in wild type cells is signi®cantly more severe. Furthermore, over-expression of CDC55 in E4orf4-expressing cells does not reverse E4orf4-induced toxicity, but rather exacerbates it (data not shown). E4orf4 could thus be used as a probe to identify downstream targets and/or functions of PP2A which are modulated by its expression. In light of the E4orf4-induced mitotic delay (Figure 4) , possible targets include regulators of the Cdc28 kinase. Previous studies in S. cerevisiae have implicated PP2A in mitotic control (Minshull et al., 1996; Wang and Burke, 1997) and experiments to address the involvement of E4orf4 in this process are underway. Provided that the downstream eects of E4orf4 in yeast are similar to those in mammalian cells, this system has potential to help de®ne the mechanism used by E4orf4 in its p53-independent killing of transformed cells. In conclusion, we believe that S. cerevisiae will provide a highly informative model system in which to study PP2A and E4orf4 functions.
Materials and methods

Yeast strains, media and culture conditions
All studies were performed using haploid S. cerevisiae strains derived from the SEY6210 diploid strain (leu2-3 112 ura3-52 his3-D200 lys2-801 trp-D901 suc2-D9). The BY4742 strain (MATa his3D1 leu2DO lys2DO ura3DO) and the EGY48 strain (MATa trp1 ura3 his3 leu2::plexAop-leu2) were also used. MC75 (MATa thr5 met) and MC76 (MATa lys1 cry1) strains were used to determine the mating type of SEY6210 haploids. Yeast transformations were performed using the one-step method of Chen et al. (1992) . Transformants were selected on synthetic minimal media containing the appropriate auxotrophic supplements.
Plasmids
Wild type haemagglutinin-tagged E4orf4 (HAE4orf4), HAE4orf4 point mutants, HA-E311.6K and HA-Bax were subcloned from mammalian expression vectors into the high copy pYES2 vector (Invitrogen) under the control of the GAL1 promoter. p424GAL1-FlagCDC55 was constructed as follows. Flag tagged-CDC55 was obtained by PCR cloning from yeast genomic DNA using forward primer 5'-GGG-GTACCACTAGTATGGACTACAAAG ACGATGACGA-TAAAATGGCACAAAACAATTTTGATTTTAAATTC-3' and reverse primer 5'-AATCCCCTCGAGTTATAATGCG-GAAAAAATGAATAAATTATTAG-3', followed by restriction enzyme digest (SpeI and KpnI) and subcloning into the p424GAL1 (2 m, TRP selection) vector purchased from the American Type Culture Collection (ATCC). FlagCDC55 was also subcloned into p414ADH to make p414ADH-FlagCDC55. Plasmids p424GAL1-FlagPPH21 and p424-GAL1-FlagPPH22 were constructed in a similar manner. Flag-tagged PPH21 was obtained by PCR using forward primer 5-CGGGATCCATGGACTACAAAGACGATGAC-GATAAAATGGATACAGATTTAGATGTGCC-3' and reverse primer 5'-AATCCCCTCGAGTCATAAAAAGTAAT-CTGGCGTC-3' followed by restriction enzyme digestion (XhoI and BamHI) and subclone. Forward primer 5'-CGGGATCCATGGACTACAAAGACGATGACGATAAA-ATGGATATGGAAATTGATGACCC-3' and reverse primer 5'-GGAATTCTTATAAGAAATAATCCGGTGTC-3' were used to generate the Flag-tagged PPH22 PCR product which was digested with BamHI and EcoRI and subcloned into the p424GAL1 vector.
Gene disruptions
Gene disruptions were performed on the SEY6210 diploid strain, followed by tetrad dissection after sporulation. CDC55 and RTS1 deletions were generated by the PCR-based disruption method using the kanMX2 module, as described in Wach et al. (1994) using the pFA6-kanMX2 plasmid as template. The cdc55::kanMX2 disruption in SEY6210 was created using the 5'-disruption primer 5'-CCTCAT-AAAATCTAGCCAACA TATCGAGGTCAAACTGGAGAG-GATATCAAGCTTGCCTCG-3' and the 3'-disruption primer 5'-GAATTCAAGTTCAATTTAAATTTCAATTAAAACA-GTAGTAGTAT GTGGGG AAGATATGGGGTCGACACTG-GATGGCGGC-3'. The rts1::kanMX2 disruption was also produced in the SEY6210 strain using the 5'-disruption primer 5'-CAATATGATGCTTGGTTTCAAGCAAAGATTAATAAA-GAAGACGATATCAAGCTTGCCTCG-3' and the 3'-disruption primer 5'-CTTCGAGCTTGTAATGAATTGCTGTTTCACTG-TATCTCGCTGGTCGACACTGGATGGCGG. Bold sequences correspond to the kanMX2 module and the remainder to the 5' or 3' region of the deleted gene, as indicated. PCR products were transformed into diploid SEY6210 yeast using the high eciency method of Gietz et al. (1995) and transformants were selected on YEPD plates containing 200 mg/ml geneticin (GIBCO). Disruptions were con®rmed by PCR diagnostics.
Western Blot analysis
Whole cell extracts were prepared by resuspending cells in yeast lysis buer (25 mM TrisCl pH 7.4, containing 125 mM NaCl, 2.5 mM EDTA, 1% Triton X-100 and protease inhibitors) followed by vortexing with acid-washed glass beads (Sigma). Alternatively, whole cell extracts were also prepared using Yeast Protein Extraction Reagent (Pierce). Protein was quanti®ed by Bio-Rad protein assay reagent and 15 mg of total protein per sample was resolved by SDS ± PAGE. Separated protein was transferred to PVDF membranes (Millipore) and immunoblotted with the indicated antibodies. Mouse monoclonal anti-HA antibody (HA.11, BAbCO) and mouse monoclonal M2 Flag antibody (Kodak/ Sigma-Aldrich) were both used at 1/1000 dilution. The antiTpd3 rabbit polyclonal antiserum was a kind gift from Dr James Broach (Princeton University) and used at 1/2000 dilution. Membranes were incubated with secondary antibody linked to horse radish peroxidase (Jackson ImmunoResearch) at 1/10 000 dilution, followed by ECL detection (NEN Life Science Products).
Co-immunoprecipitation and phosphatase assays
Yeast transformed with the indicated plasmid DNAs were grown in YNB medium containing 2% (wt/v) glucose, transferred to glycerol (2%) based medium, followed by induction of gene expression in YNB galactose (2%) for 24 h. Cells were harvested and resuspended in yeast lysis buer. Cells were lysed with acid washed glass beads (Sigma) and precleared cell lysates were immunoprecipitated with either HA (HA.11, BabCO) or Flag (Kodak/Sigma-Aldrich) monoclonal antibody, followed by incubation with Protein G Sepharose beads (50% slurry in lysis buer). Immunoprecipitates were washed ®ve times with lysis buer and then eluted by boiling in sample buer. Samples were resolved by SDS ± PAGE using gels containing 10 or 12% polyacrylamide and analysed by Western blotting using the appropriate antibody. For phosphatase assays, the precipitates were washed ®ve times in lysis buer and once in Ser/Thr phosphatase buer (50 mM Tris-HCl, pH 7, 0.1 mM CaCl 2 ) and activity against a synthetic phosphopeptide substrate was assayed using a malachite green-based assay kit (Upstate Biotechnology).
Spotting assays
Yeast cells were grown in liquid YNB glucose (2% wt/vol)-based medium followed by YNB containing 2% glycerol or 2% ranose in the case of the rts1 deletion strain. Equal numbers of cells were serially diluted and spotted onto YNB agar plates containing 2% galactose and 1% glycerol/1% ranose to induce gene expression from the GAL1 promoter or onto YNB glucose (2%) control plates. Photographs were taken on the indicated day post-galactose induction.
FACS analysis
Wild type yeast transformed with pYES2-HAE4orf4 or vector alone were collected 24 h after galactose induction. Cells were prepared for cell cycle analysis following the method outlined in Dien et al. (1994) . Propidium iodide stained cells were acquired on a FACScan instrument and analysed with WinMDI software.
Immunoprecipitation-kinase assay
Wild type or cdc55 strains of yeast expressing vector or E4orf4 were induced in galactose medium for 24 h. Cells were lysed as described above and 300 mg of whole cell extract was immunoprecipitated with 1 mg of rabbit polyclonal Clb2 antibody and protein A Sepharose beads (50% slurry). Precipitates were washed ®ve times in lysis buer and once in kinase assay buer (50 mM HEPES, pH 7.5, 1 mM EGTA, 2 mM MgCl 2 , 1 mM DTT). Each precipitate was incubated for 30 min at 308C in 20 ml of reaction mix containing kinase assay buer, 5 mM cold ATP, 10 mg H1 Histone (Sigma), and 10 mCi g [P 32 ]-ATP (6000 Ci/mmol speci®c activity). Kinase reactions were stopped by adding 10 ml of 46sample buer followed by boiling for 5 min. Reactions were subject to SDS ± PAGE containing 10 ml polyacrylamide and transferred to PVDF. Membranes were exposed to ®lm (Kodak, Biomax MR) to visualize the level of H1 phosphorylation.
Colony formation assay
SEY6210 wild type yeast containing either vector alone, pYES2-HAE4orf4 or pYES2-HABax plasmid were grown in YNB glucose liquid medium, then transferred to glycerolcontaining medium. Cells were transferred to galactose medium to induce protein expression. At the indicated times post-induction, approximately 300 cells were plated in triplicate on to glucose-based medium and incubated at 308C. Colonies formed were counted 48 h post-incubation.
